The aim of this study was to describe the kinetics of the cytokine release and the expression of activation markers on lymphocytes after stimulation of peripheral blood mononuclear cells (PBMC) with whole killed Streptococcus pneumoniae. The cytokine release and the expression of CD25 and HLA-DR on T cells, and CD69 on T cells, B cells and NK cells, were measured at different times. Our results show that tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-10 and IL-12 reached maximal levels at 24 h, while IL-6, IL-8, TNF-beta and interferon (IFN)-gamma increased throughout the 1-week test period. The strains tested gave an increased expression of CD69 on all cell types, as well as an increase of CD25 and HLA-DR expression on T cells. The maximal CD69 expression was seen after 24 h on T cells and NK cells, while the B-cell expression of CD69 reached a plateau at the same time. All the cells still expressed CD69 on their surfaces after 1 week. In conclusion the results indicate that there was probably an early activation of monocytes leading to a polyclonal activation of lymphocytes.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-3083.1999.00470.xDOI Listing

Publication Analysis

Top Keywords

cytokine release
12
release expression
12
cells cells
12
cells
10
kinetics cytokine
8
activation markers
8
peripheral blood
8
blood mononuclear
8
mononuclear cells
8
streptococcus pneumoniae
8

Similar Publications

Chronic Obstructive Pulmonary Disease (COPD) is a poorly reversible respiratory disorder distinguished by dyspnea, cough, expectoration and exacerbations due to abnormality of airways or emphysema. In this review, we consider the therapeutic potential of targeting Mammalian target of Rapamycin (mTOR) for treating COPD. The mTOR is a highly conserved serine-threonine protein kinase that integrates signals from growth factors and nutrients to control protein synthesis, lipid biogenesis and metabolism.

View Article and Find Full Text PDF
Article Synopsis
  • FT596 is a novel cancer therapy using iPSC-derived CAR NK cells targeting CD19, designed to assess its safe dosage and effectiveness alone and with rituximab in patients with B-cell lymphoma.
  • This phase 1 trial involved patients with relapsed or refractory B-cell lymphoma, administering FT596 after chemotherapy, with separate regimens for those receiving rituximab and those who did not.
  • The study measured potential side effects while determining the optimal dose of FT596 and allowed modifications to the treatment based on patient tolerance and response.
View Article and Find Full Text PDF

Background: Ginseng-Schisandra chinensis (GSC) decoction has shown good efficacy in the treatment of asthma, but its t mechanism in the treatment of asthma is still not fully understood.

Purpose: This study aims to elucidate the therapeutic mechanism of GSC for AS by identifying the active components of GSC.

Methods: The chemical composition of GSC was analyzed using UHPLC-MS/MS.

View Article and Find Full Text PDF

Baicalin ameliorates neuroinflammation by targeting TLR4/MD2 complex on microglia via PI3K/AKT/NF-κB signaling pathway.

Neuropharmacology

January 2025

National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710119, China. Electronic address:

This study aims to elucidate the target and mechanism of baicalin, a clinically utilized drug, in the treatment of neuroinflammatory diseases. Neuroinflammation, characterized by the activation of glial cells and the release of various pro-inflammatory cytokines, plays a critical role in the pathogenesis of various diseases, including spinal cord injury (SCI). The remission of such diseases is significantly dependent on the improvement of inflammatory microenvironment.

View Article and Find Full Text PDF

Background: Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology. This study aims to explore the potential mechanisms by which solute carrier family 7 member 11 (SLC7A11) influences RA development.

Methods: Collagen-induced arthritis (CIA) mice were constructed to observe disease onset and pathological scores.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!